<DOC>
	<DOCNO>NCT01850160</DOCNO>
	<brief_summary>This trial aim assess efficacy safety fixed-dose combination therapy Valsartan Chlorthalidone , Vs Valsartan Chlorthalidone alone treatment adult patient diagnosis arterial hypertension .</brief_summary>
	<brief_title>Efficacy/Safety Study Valsartan Chlorthalidone Conjugate Treatment Compared Simple Treatment Hypertension</brief_title>
	<detailed_description>In spite existence great variety treatment drug effective arterial hypertension , percentages arterial hypertension control monotherapy remain quite low reason fixed-dose combination drug one interest research topic order achieve appropriate control arterial hypertension . The possibility achieve good coverage Blood Pressure control drug combination lead , scientific base efficacy Angiotensin Receptor Blockers II plus diuretic combination , development great number combination different Angiotensin II Receptor Blockers plus hydrochlorothiazide . Yet noteworthy despite increase evidence show additional benefit Blood pressure control reduction cardiovascular outcome chlorthalidone hydrochlorothiazide , neither great number combination study Angiotensin II Receptor Blockers plus chlorthalidone whereby conduction trial assess efficacy safety Valsartan plus chlorthalidone hypertensive patient propose plus benefit combination therapy include , among others , great efficacy low dos individual component well reduction occurrence adverse event directly relate low drug doses.With treatment schedule expect obtain high control blood pressure value great percentage patient .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Sodium Chloride Symporter Inhibitors</mesh_term>
	<mesh_term>Angiotensin II</mesh_term>
	<criteria>Patient diagnosis arterial hypertension define : Systolic blood pressure great equal 140 low 180 mmHg Diastolic blood pressure great equal 90 low 110 mmHg Non control patient antihypertensive treatment ( blood pressure value : Systolic blood pressure &gt; 140 mmHg and/or Diastolic blood pressure &gt; 90 mmHg ) patient antihypertensive treatmentna√Øve . Likelihood attend consultation accord trial chronogram . Informed Consent Signature . Diagnosis severe malignant arterial hypertension define : Systolic blood pressure great equal 180 mmHg Diastolic blood pressure great equal 110 mmHg Patients secondary arterial hypertension etiology . Pregnant woman woman childbearing potential use appropriate contraception method ; woman plan become pregnant trial . Patients history Acute Myocardial Infarction Angina Pectoris within 6 month prior trial initiation . Diagnosis Cerebrovascular Disease ( CVD ) Transient Ischemic Attack ( TIA ) within 6 previous month . Patients Severe Renal Disease define serum Creatinine level higher 1.5 mg/dl . Diagnosed suspected unilateral bilateral renal artery stenosis . History non remit cancer within 5 year prior trial initiation . Patients Hypokalemia Hyperkalemia . Patients receive Valsartan Chlortalidone 14 previous day . Patients know hypersensitivity Valsartan Chlorthalidone . Unstable patient antecedent hospitalization within 4 day prior enrollment trial . Patients history drug alcohol abuse within last year . Patients take part clinical trial within 4 week prior initiation research . Patients clinical condition investigator deems may affect patient followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>High blood pressure</keyword>
	<keyword>Drug therapy combination</keyword>
	<keyword>Valsartan</keyword>
	<keyword>Chlorthalidone</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>